Medical masks comparable to N95 respirators for preventing COVID-19? Dr. Nandita Mohan1 Dec 2022 4:00 AMA study of more than 1,000 health care workers was unable to establish whether medical masks are significantly less effective at preventing COVID-19...
Monoclonal antibody treatment for COVID-19 stands safe in pregnancy: Study Dr. Kamal Kant Kohli28 Nov 2022 4:15 AMPennsylvania : A single-center study published in Annals of Internal Medicine found that monoclonal antibody therapy for COVID-19 was safe to use...
Higher bicarbonate excretion in cystic fibrosis predicts better lung function and pancreatic sufficiency Aditi24 Nov 2022 2:30 PMDenmark: A study published in the Annals of Internal Medicine has concluded that challenged urine bicarbonate excretion is a new, simple, and safe...
Total Ankle Replacement as good as Arthrodesis for patients with advanced Ankle Osteoarthritis Dr. Kamal Kant Kohli19 Nov 2022 4:45 AMUCL researchers have found in TARVA randomised clinical trial that among patients with advanced ankle osteoarthritis who opt surgery equally good...
Subcutaneous ICD reduces lead-related complications without compromising effectiveness of ICD shocks Dr. Kamal Kant Kohli10 Nov 2022 2:00 PMImplantable cardioverter defibrillators (ICDs) improve survival in patients at risk for cardiac arrest, but are associated with intravascular...
Sigmoidoscopy screening improves Colorectal cancer incidence and mortality Dr. Kamal Kant Kohli7 Nov 2022 4:00 AMNORWAY: Sigmoidoscopy screening reduces colorectal cancer (CRC) incidence and death significantly and sustainably over 15 years, according to a pooled...
Urine bicarbonate test offers new, safe quantification of CFTR function in cystic fibrosis patients Dr. Kamal Kant Kohli1 Nov 2022 4:00 AMA study of 50 adult patients with cystic fibrosis (CF) has found that challenged urine bicarbonate excretion may offer a new, simple, and safe...
Ticagrelor-aspirin antiplatelet therapy more beneficial in persons with normal renal function Dr. Kamal Kant Kohli31 Oct 2022 9:15 PMAn analysis of the CHANCE-2 trial has found that persons with normal renal function receive greater benefit from antiplatelet therapy with...
Apixaban associated with lower risk of GI bleeding compared to all DOACs Dr. Kamal Kant Kohli31 Oct 2022 9:15 PMA multinational cohort study of persons with atrial fibrillation (AF) found that compared with all direct oral anticoagulants (DOACs), apixaban was...
Vitamin D deficiency associated with increased mortality, finds large study Dr. Kamal Kant Kohli25 Oct 2022 1:45 AMLow vitamin D status has been linked to increased mortality, but mortality in the context of vitamin D deficiency remains unclear. Randomized...
Stroke, systemic embolism risk halved in AF patients with VHD who took apixaban versus Rivaroxaban Dr. Kamal Kant Kohli20 Oct 2022 6:15 AMAccording to researchers at the Perelman School of Medicine at the University of Pennsylvania patients of Atrial fibrillation with VHD receiving...
SGLT2 inhibitors and GLP1 receptor antagonists effectively control blood sugar but are prohibitively expensive Dr. Kamal Kant Kohli13 Oct 2022 2:00 PMSGLT2 and GLP1 have been found to reduce atherosclerotic cardiovascular disease (ASCVD), microvascular disease, and mortality in addition to improving...
